Controlled drug delivery to the inner ear using ApidSOL/ApidCOR technology

• Unité de recherche: INNOSUISSE
• Numéro de projet: 17673.2 PFLS-LS
• Titre du projet anglais: Controlled drug delivery to the inner ear using ApidSOL/ApidCOR technology

Description succincte (Allemand)

Controlled drug delivery to the inner ear using ApidSOL/ApidCOR technology

Description succincte (Anglais)

Controlled drug delivery to the inner ear using ApidSOL/ApidCOR technology

Résumé des résultats (Abstract) (Allemand)

Local drug delivery is an important topic for innovative treatments of inner ear diseases, such as hearing loss,|because of increased efficacy and decreased side effects. We propose to use Apidel proprietary drug delivery|technologies to optimize local inner ear administration of an established otoprotective drug (dexamethasone)|and an innovative and otoactive anti NOX3 siRNA. The results are expected to open important market|segments for Apidel.

Résumé des résultats (Abstract) (Anglais)

Local drug delivery is an important topic for innovative treatments of inner ear diseases, such as hearing loss,|because of increased efficacy and decreased side effects. We propose to use Apidel proprietary drug delivery|technologies to optimize local inner ear administration of an established otoprotective drug (dexamethasone)|and an innovative and otoactive anti NOX3 siRNA. The results are expected to open important market|segments for Apidel.